The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of BCL-2 increases both their number and repopulation potential

Journal of Experimental Medicine

Volumn 191, Issue 2, 2000, Pages 253-263

  Domen, Jos ^a,b   Cheshier, Samuel H ^a   Weissman, Irving L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Apoptosis; BCL 2; Hematopoietic stem cells; Homeostasis

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL COUNT; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0034677173     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.191.2.253     Document Type: Article

References (46)

1. Bradford, G.B., B. Williams, R. Rossi, and I. Bertoncello. 1997. Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp. Hematol. 25:445-453.
2. Cheshier, S.H., S.J. Morrison, X. Liao, and I.L. Weissman. 1999. In vivo proliferation and cell cycle kinetics of long-term hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 96: 3120-3125.
3. Morrison, S.J., A.M. Wandycz, K. Akashi, A. Globerson, and I.L. Weissman. 1996. The aging of hematopoietic stem. Nat. Med. 9:1011-1016.
4. McDonnell, T.J., N. Deane, F.M. Platt, G. Nunez, U. Jaeger, J.P. McKearn, and S.J. Korsmeyer. 1989. bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57:79-88.
5. Strasser, A., A.W. Harris, and S. Cory. 1991. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
6. Sentman, C.L., J.R. Shutter, D. Hockenbery, O. Kanagawa, and S.J. Korsmeyer. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67: 879-888.
7. Lagasse, E., and I.L. Weissman. 1997. Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell. 89:1021-1031.
8. Domen, J., and I.L. Weissman. 1999. Self-renewal, differentiation or death: regulation and manipulation of hematopoietic stem cell fate. Mol. Med. Today. 5:201-208.
9. Chao, D.T., and S.J. Korsmeyer. 1998. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:395-419.
10. Ashkenazi, A., and V.M. Dixit. 1998. Death receptors: signaling and modulation. Science. 281:1305-1308.
11. Adams, J.M., and S. Cory. 1998. The Bcl-2 protein family: arbiters of cell survival. Science. 281:1322-1326.
12. Vaux, D.L., and S.J. Korsmeyer. 1999. Cell death in development. Cell. 96:245-254.
13. Bakhshi, A., J.P. Jensen, P. Goldman, J.J. Wright, O.W. McBride, A.L. Epstein, and S.J. Korsmeyer. 1985. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell. 41:899-906.
14. Cleary, M.L., S.D. Smith, and J. Sklar. 1986. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 47:19-28.
15. Tsujimoto, Y., and G.M. Croce. 1986. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA. 83:5214-5218.
16. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440-442.
17. Vaux, D.L., H.L. Aguila, and I.L Weissman. 1992. Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing. Int. Immunol. 4:821-824.
18. Sutton, V.R., D.L. Vaux, and J.A. Trapani. 1997. Bcl-2 prevents apoptosis induced by perform and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J. Immunol. 158:5783-5790.
19. Reap, E.A., N.J. Felix, P.A. Wolthusen, B.L. Kotzin, P.L. Cohen, and R.A. Eisenberg. 1995. bcl-2 transgenic Lpr mice show profound enhancement of lymphadenopathy. J. Immunol. 155:5455-5462.
20. Strasser, A., A.W. Harris, D.C. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO (Eur. Mol. Biol. Organ) J. 14:6136-6147.
21. Traver, D., K. Akashi, I.L. Weissman, and E. Lagasse. 1998. Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity. 9:47-57.
22. Mazel, S., D. Burtrum, and H.T. Petrie. 1996. Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J. Exp. Med. 183:2219-2226.
23. Brady, H.J., G. Gil-Gomez, J. Kirberg, and A.J. Berns. 1996. Bax alpha perturbs T cell development and affects cell cycle entry of T cells. EMBO (Eur. Mol. Biol. Organ) J. 15:6991-7001.
24. Fairbairn, L.J., G.J. Cowling, B.M. Reipert, and T.M. Dexter. 1993. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors. Cell. 74:823-832.
25. Kondo, M., K. Akashi, J. Domen, K. Sugamura, and I.L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice. Immunity. 7:155-162.
26. Akashi, K., M. Kondo, U. von Freeden-Jeffry, R. Murray, and I.L. Weissman. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell. 89:1033-1041.
27. Maraskovsky, E., L.A. O'Reilly, M. Teepe, L.M. Corcoran, J.J. Peschon, and A. Strasser. 1997. Bcl-2 can rescue T lymphocyte development in interleukin-7 receptor-deficient mice but not in mutant rag-1-/-mice. Cell. 89:1011-1019.
28. Bauman, J.G., P. de Vries, B. Pronk, and J.W. Visser. 1988. Purification of niunne hemopoietic stem cells and committed progenitors by fluorescence activated cell sorting using wheat germ agglutinin and monoclonal antibodies. Acta Histochem. Suppl. 36:241-253.
29. Spangrude, G.J., and R. Scollay. 1990. Differentiation of hematopoietic stem cells in irradiated mouse thymic lobes. Kinetics and phenotype of progeny. J. Immunol. 145:3661-3668.
30. Domen, J., K.L. Gandy, and I.L. Weissman. 1998. Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood. 91:2272-2282.
31. Morrison, S.J., and I.L. Weissman. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity. 1:661-673.
32. Randall, T.D., and I.L. Weissman. 1997. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 89:3596-3606.
33. Lagasse, E., and I.L. Weissman. 1994. bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J. Exp. Med 179:1047-1052.
34. Morrison, S.J., H.D. Hemmati, A.M. Wandycz, and I.L. Weissman. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA. 92:10302-10306.
35. Farlie, P.G., R. Dringen, S.M. Rees, G. Kannourakis, and O. Bernard. 1995. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA. 92:4397-4401.
36. Necas, E., L. Sefc, G. Brecher, and N. Bookstein. 1995. Hematopoietic reserve provided by spleen colony-forming units (CFU-S). Exp. Hematol. 23:1242-1246.
37. Necas, E., L. Sefc, K. Sulc, E. Barthel, and H.J. Seidel. 1998. Estimation of extent of cell death in different stages of normal murine hematopoiesis. Stem Cells. 16:107-111.
38. Moore, K.A., B. Pytowski, L. Witte, D. Hicklin, and I.R. Lemischka. 1997. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc. Natl. Acad. Sci. USA. 94:4011-4016.
39. Varnum-Finney, B., L.E. Purton, M. Yu, C. Brashem-Stein, D. Flowers, S. Staats, K.A. Moore, I. Le Roux, R. Mann, G. Gray, et al. 1998. The notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood. 91:4084-4091.
40. Jones, P., G. May, L. Healy, J. Brown, G. Hoyne, S. Delassus, and T. Enver. 1998. Stromal expression of Jagged 1 promotes colony formation by fetal hematopoietic progenitor cells. Blood. 92:1505-1511.
41. Morrison, S.J., D.E. Wright, and I.L. Weissman. 1997. Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc. Natl. Acad. Sci. USA. 94:1908-1913.
42. Yang, E., and S.J. Korsmeyer. 1996. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood. 8:386-401.
43. Ekert, P.G., and D.L. Vaux. 1997. Apoptosis, haemopoiesis and leukaemogenesis. Baillieres Clin. Haematol. 10:561-576.
44. Cory, S., D.L. Vaux, A. Strasser, A.W. Harris, and J.M. Adams. 1999. Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation. Cancer Res. 59:1685s-1692s.
45. O'Reilly, L.A., D.C. Huang, and A. Strasser. 1996. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO (Eur. Mol. Biol. Organ.) J. 15: 6979-6990.
46. de Haan, G., and G. Van Zant. 1997. Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene. J. Exp. Med. 186:529-536.